Cedars-Sinai Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Cedars-Sinai Medical Center sits in the top decile of US sponsors by registered trial count (#106 of 15,742 sponsors by registered trial count).
Cedars-Sinai Medical Center: 339 sponsored US clinical trials, 70 recruiting.
Cedars-Sinai Medical Center sponsors 339 registered US clinical trials on ClinicalTrials.gov, 70 of them currently recruiting, and 180 completed. 42 of these trials are in Phase 3-4 (later-stage) and 83 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bladder Cancer, with 6 trials.
Top-decile sponsor footprint
Cedars-Sinai Medical Center ranks in the top decile of sponsors by registered trial count (#106 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
180 of 230 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
339 total, page 1 of 7
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
NCT07223385
Ongoing Lung Decline With Age Intensified Response
NCT07676435
Virtual Reality for ICU Delirium Prevention
NCT07357389
Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
NCT07224607
Proactive Costs of Care Study
NCT07217262
Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center
NCT06897982
Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures
NCT07299474
Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
NCT06567717
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
NCT06856694
This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device
NCT06965803
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
NCT07124351
Food is Medicine Prospective Study
NCT07169448
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
NCT07017673
Family Foundations for Individuals Pregnant Via ART
NCT06770972
Enhanced Recovery After Surgery (ERAS) for Complicated Appendicitis
NCT06948071
Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)
NCT06988150
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
NCT06877169
Transcatheter vs. Surgical Treatment of Degenerative Mitral Regurgitation
NCT07605715
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
NCT06817148
Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis
NCT05771675
Esophageal Temperature During PVI Using Q-DOT Micro
NCT06392932
Diet in the Management of Acromegaly
NCT05401084
Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy
NCT06567821
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
NCT06437574
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
NCT06338865
Blunt Fascial vs. Veress Needle Peritoneal Entry in Laparoscopic Gynecologic Surgery
NCT06305975
Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study
NCT06016257
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
NCT05923684
Managing Kyphosis With Exercise
NCT06082739
The Effectiveness of Immersive Virtual Reality as a Pain Control Modality After Hip Arthroscopy
NCT05868369
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
NCT05653258
Impact of Protect Your Colon™ on CRC Screening
NCT05929820
LEAPTogether: An Intergenerational Intervention to Address Loneliness and Social Isolation
NCT05831475
Conservative Treatment of Trigger Finger
NCT05837286
MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
NCT05699213
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
NCT05708352
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
NCT05552053
A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis
NCT05664880
Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors
NCT05391217
Benefits of Endoscopic Bariatric Procedures
NCT05514288
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
NCT05086250
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
NCT05298605
Avoid and Resist Strategies for Weight Management
NCT05143931
Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)
NCT05275686
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
NCT04722341
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
NCT05139797
MS-ResearchBiomarkerS
NCT05204459
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
NCT04979338
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NCT04907643
Predicting BCG Response
NCT04564781
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 43 |
| Phase 2 | 40 |
| Phase 3 | 9 |
| Phase 4 | 33 |
What is open in the Cedars-Sinai Medical Center pipeline
70 recruiting of 339 indexed (21% open); 180 completed (53%).
Phase mix: 42 late (III/IV) vs 83 early (I/II) (early-phase heavy).
Top condition: Bladder Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cedars-Sinai Medical Center: open-pipeline peers nationwide
Peers matched on 339 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Cedars-Sinai Medical Center sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 339 trials (± recruiting share)
- National Institutes of Health Clinical Center (CC) · 338 trials · 7% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
- National Institute of Mental Health (NIMH) · 343 trials · 12% recruiting
Sponsors near 21% open enrollment (± trial volume)
- University of Colorado, Denver · 21% recruiting · 1,283 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this Cedars-Sinai Medical Center page
339 registered trials is a research-attention snapshot, not an endorsement of Cedars-Sinai Medical Center or any single study.
- 70 of Cedars-Sinai Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bladder Cancer is the condition Cedars-Sinai Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bladder Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Cedars-Sinai Medical Center pipeline card: 339 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.